Cover Image

Can calcitonin gene‐related peptide monoclonal antibodies ameliorate writer's cramp and migraine?

Abstract Recently, calcitonin gene‐related peptide (CGRP) monoclonal antibodies (mAbs) have become available as a prophylactic treatment for migraine and have shown high efficacy and safety in clinical practice. CGRP mAbs have been reported to be effective not only for migraine but also for other co...

Full description

Saved in:

Bibliographic Details
Main Authors:	Keisuke Suzuki (Author), Shiho Suzuki (Author), Hiroaki Fujita (Author), Hirotaka Sakuramoto (Author), Mukuto Shioda (Author), Koichi Hirata (Author)
Format:	Book
Published:	Wiley, 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluating the wearing-off effects of fremanezumab in high-frequency episodic migraine and chronic migraine: A real-world observational study in Japan
by: Shiho Suzuki, et al.
Published: (2023)

New Trends in Migraine Pharmacology: Targeting Calcitonin Gene-Related Peptide (CGRP) With Monoclonal Antibodies
by: Damiana Scuteri, et al.
Published: (2019)

Tolerability of calcitonin gene-related peptide monoclonal antibodies and other monoclonal antibodies in adults with concurrent migraine and other medical conditions
by: Kevin Weber, et al.
Published: (2024)

Monoclonal antibodies against calcitonin gene-related peptide in chronic migraine: an adjusted indirect treatment comparison
by: María del Pilar Briceño-Casado, et al.
Published: (2020)

Dystonia and Writer's Cramp Triggered by Exercise
by: J Gordon Millichap
Published: (1997)

Basal Ganglia A-V Malformation and Writer's Cramp
by: J Gordon Millichap
Published: (1998)

Efficacy and Safety of Monoclonal Antibody Against Calcitonin Gene-Related Peptide or Its Receptor for Migraine: A Systematic Review and Network Meta-analysis
by: Xing Wang, et al.
Published: (2021)

Calcitonin Gene-Related Peptide Monoclonal Antibody Versus Botulinum Toxin for the Preventive Treatment of Chronic Migraine: Evidence From Indirect Treatment Comparison
by: Jiajie Lu, et al.
Published: (2021)

Placebo response with subcutaneous injections in calcitonin gene-related peptide receptor monoclonal antibody migraine preventative trials - A systematic review and meta-analysis
by: Sasikanth Gorantla, et al.
Published: (2022)

Pharmacokinetics, Pharmacodynamics and Drug-Drug Interactions of New Anti-Migraine Drugs-Lasmiditan, Gepants, and Calcitonin-Gene-Related Peptide (CGRP) Receptor Monoclonal Antibodies
by: Danuta Szkutnik-Fiedler
Published: (2020)

Calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraines in adults
by: Eric R Ocheretyaner, et al.
Published: (2022)

Calcitonin Gene-Related Peptide (CGRP)-Targeted Treatments-New Therapeutic Technologies for Migraine
by: Linda Sangalli, et al.
Published: (2023)

Calcitonin Gene-Related Peptide Monoclonal Antibodies Versus Botulinum Neurotoxin a in the Preventive Treatment of Chronic Migraine: An Adjusted Indirect Treatment Comparison Meta-Analysis
by: Yao-Yao Chen, et al.
Published: (2021)

Sensitive training through body awareness to improve the writing of patients with writer's cramp
by: Flavia Quadros Boisson Waissman, et al.
Published: (2013)

Network Meta-Analysis of Calcitonin Gene-Related Peptide Receptor Antagonists for the Acute Treatment of Migraine
by: Fang Xu, et al.
Published: (2019)

Erenumab: A novel calcitonin gene-related peptide receptor antagonist developed specifically for migraine prevention
by: Shuchita Garg, et al.
Published: (2020)

Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis
by: Casper Emil Christensen, et al.
Published: (2022)

Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
by: Wenfang Sun, et al.
Published: (2024)

Constipation as a possible predictor of poor treatment response in chronic migraine: A retrospective study of anti-calcitonin gene-related peptide (anti-CGRP) monoclonal antibodies and the impact of switching
by: Sena Uzun, et al.
Published: (2024)

Improvement of comorbid anxiety and depression in patients with migraine treated with injectable preventive calcitonin gene-related peptide antagonists: Review of clinical evidence
by: Abubker Omaer, et al.
Published: (2024)

Transient glyphosate encephalopathy due to a suicide attempt
by: Saaya Yokoyama, et al.
Published: (2021)

The Mechanism of Calcitonin Gene-Related Peptide-Containing Nerve Innervation
by: Narumi Hashikawa-Hobara, et al.
Published: (2012)

Exogenous murine antimicrobial peptide CRAMP significantly exacerbates Ovalbumin-induced airway inflammation but ameliorates oxazolone-induced intestinal colitis in BALB/c mice
by: Yang Li, et al.
Published: (2018)

A Post-Liver Transplant Girl With Recurrent Cramps in the Legs
by: Jiro Abe MD, et al.
Published: (2015)

Monoclonal antibodies blocking CGRP for prevention of migraine
by: Alicja Maziarczyk, et al.
Published: (2023)

The Memoirs of Charles H. Cramp
by: Buell, Augustus C., 1847-1904

Expression of calcitonin gene-related peptide and pulp sensitivity tests in irreversible pulpitis
by: Brenda Eréndida CASTILLO-SILVA, et al.

Calcitonin gene‐related peptide: An intra‐articular therapeutic target for TMJ disorders
by: Sabine M. Brouxhon, et al.
Published: (2022)

Anti-CGRP monoclonal antibodies in the treatment of migraine in women: impact on menstrual relared migraine and algodysmenorrhea
by: Anna V. Berdnikova, et al.
Published: (2023)

Oral calcitonin
by: Hamdy RC, et al.
Published: (2012)

Spasmodic Muscle Cramps and Wilson Disease
by: J Gordon Millichap
Published: (2013)

Assessing the immunogenicity risk of salmon calcitonin peptide impurities using in silico and in vitro methods
by: Brian J. Roberts, et al.
Published: (2024)

EFFECTIVENESS OF MAGNESIUM CITRATE ADJUNCTIVE THERAPY ON CRAMPING PAIN INTENSITY IN NOCTURNAL LEG CRAMPS PATIENTS AT BETHESDA HOSPITAL YOGYAKARTA
by: Ananda Digdoyo, et al.
Published: (2024)

Lipidated Calcitonin Gene-Related Peptide (CGRP) Peptide Antagonists Retain CGRP Receptor Activity and Attenuate CGRP Action In Vivo
by: Aqfan Jamaluddin, et al.
Published: (2022)

The effect of acupressure on muscle cramps in patients undergoing hemodialysis
by: Kolsoom Mohmadi, et al.
Published: (2016)

Exercise-associated Muscle Cramps in Runners: A Review
by: Ali Fattahi, et al.
Published: (2021)

Exercise-associated Muscle Cramps in Runners: A Review
by: Ali Fattahi, et al.
Published: (2021)

Sensory neurons expressing calcitonin gene-related peptide α regulate adaptive thermogenesis and diet-induced obesity
by: Kuldeep Makwana, et al.
Published: (2021)

Calcitonin gene-related peptide promotes cellular changes in trigeminal neurons and glia implicated in peripheral and central sensitization
by: Cady Ryan J, et al.
Published: (2011)

Effects of NSAIDs on the Release of Calcitonin Gene-Related Peptide and Prostaglandin E2 from Rat Trigeminal Ganglia
by: Vittorio Vellani, et al.
Published: (2017)